AD and MCI Research Study

The purpose of this study is to investigate how Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) affect brain activity. Non-invasive brain imaging instruments will be used (MEG and MRI), and participants will complete a variety of mental activities. Those diagnosed with Alzheimer's Disease or MCI may also receive an amyloid-beta PET scan (if they have not previously had one) which may be beneficial for diagnosis and treatment.   

• Who is eligible? Adults diagnosed with Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI), or healthy adults without history of psychiatric or neurological disease. 

  Age: 55+ years 

  Compensation: $75 per visit (first 3 visits), $50 for PET visit 

  Time: 3 hours per visit (3 visits), plus 1-hour PET visit (if AD or MCI) 

  Visit Type: In-person 

  Location: Institute for Human Neuroscience - Boys Town Main (West) Campus 

  Requirements: Have not had a stroke or any other major neurologic disease (aside from AD or MCI), have not been diagnosed with any psychiatric disorder, are able to complete a series of mental tasks, have been diagnosed with Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI), OR healthy adult without history of psychiatric or neurologic disease. 

Fill out the form below and we will be in contact soon!